Bentham Science Logo

Current Pharmacogenomics and Personalized Medicine

Formerly: Current Pharmacogenomics

Volume 17, 3 Issues, 2019
ISSN: 1875-6913 (Online)
ISSN: 1875-6921 (Print)
This journal supports open access

Aims & Scope

Current Pharmacogenomics and Personalized Medicine (CPPM) is a transdisciplinary peer-reviewed biomedical journal that reports new findings and cutting-edge concepts in both pharmacogenomics and personalized medicine under a single cover. CPPM is an accelerator for global personalized medicine and pharmacogenomics. Importantly, the journal provides a multi-disciplinary integrated platform from cell to society to address diagnostics and responsible pharmacogenomics applications in developing countries.

CPPM cooperates with the Ibero-American Network of Pharmacogenetics and the Pacific Rim Association for Clinical Pharmacogenetics and welcomes peer reviewed contributions from qualified authors in any global region including the Central and Latin American countries, Asia-Pacific and developing countries.

The Journal scope is defined by three inter-connected aims. First, we are interested in genomics/postgenomics biotechnologies and diagnostics that enable global personalized medicine science (including and beyond pharmacogenomics) as long as they explain person-to-person and population differences in disease susceptibility or response to a health intervention, and they can be mechanistically substantiated. Second, we approach personalized medicine as ‘personalized health interventions’ focusing primarily on drug therapy, but also other interventions such as nutrition, vaccines, surgical devices, emerging cell-based therapies that collectively contribute to healthcare. Third, we strive to integrate molecular and clinical investigation with public policy, global health diplomacy and social studies of biotechnology that collectively shape postgenomics future(s) and innovation trajectories in life sciences. Priority will be given to expert reviews and research articles that include original ideas and findings related to the journal scope and mandate.

This journal follows the International Committee of Medical Journal Editors (ICMJE) (www.icmje.org) guidance for authorship, peer review and editorial independence. All manuscripts submitted for publication will be immediately subjected to editorial scrutiny. Manuscripts that do not conform to the CPPM format and editorial style will be returned to the authors. Only those articles that may potentially pass the rigorous standards of the peer review process are sent out for critical appraisal by independent expert referees invited from the international editorial board and the broader scientific community.

CPPM offers a transdisciplinary, peer-reviewed and intellectually stimulating forum for academic researchers, health professionals, pharmaceutical and biotechnology industries, policy makers, government and global health stakeholders interested in pharmacogenomics and global personalized medicine. The journal is published two times per year and printed on acid-free paper.

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)

,

Volume 16

-

Number 3



Biography   Open Access



Review Article   Open Access



Review Article   Open Access



Review Article   Open Access



Research Article   Open Access



Research Article   Open Access



Research Article



Acknowledgement   Open Access



Articles Ahead of Print

There are currently no Articles Ahead of Print available for this journal.

Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Editor's Choice



The Gut Microbiota in Cardiovascular Diseases: From Biomarkers and Potential Targets to Personalized Interventions

, 2018; 16(1): 75 - 85

Yaroslav I. Ashikhmin, Abram L. Syrkin, Andrey A. Zamyatnin Jr.*, Yong Zhang and Philipp Yu. Kopylov*


DOI: 10.2174/1875692116666180511170329




Cardiovascular Pharmacogenomics

, 2017; 15(1): 67 - 80

Valentina Manzo*, Sara Tarallo, Teresa Iannaccone, Maria Costantino, Walter Filippelli and Amelia Filippelli


DOI: 10.2174/1875692115666170503124456



Gender Differences in Response to Therapy for Cardiovascular Diseases

, 2017; 15(1): 14 - 26

Corbi Graziamaria*, Ambrosino Immacolata, Komici Klara, Cellurale Michele, Lombardi Anna and Ferrara Nicola


DOI: 10.2174/1875692115666170508153322



Allele Frequencies of CYP2D6, CYP3A5 and DPYD Genes Polymorphisms in the Healthy Yakut Population

, 2016; 14(1): 50 - 55

Filipp F. Vasilyev, Diana A. Danilova, Vladimir S. Kaimonov, Yana V. Chertovskih and Nadezda R. Maksimova


DOI: 10.2174/1875692114666160801151257




Exome-wide pharmacogenomic analysis of response to thiopurines in inflammatory bowel disease patients

, 2015; 13(1): 61 - 67

William Zabala, Raquel Cruz, Manuel Barreiro-de Acosta, María Chaparro, Julián Panes, Ana Echarri, Maria Esteve, Daniel Carpio, Montserrat Andreu, Esther Garcia-Planella, Eugeni Domenech, Angel Carracedo, Javier P. Gisbert, Francisco Barros and on behalf of EIGA and ENEIDA investigators


DOI: 10.2174/1875692113666150813151413




Open Access Articles


Molecular Mechanism of Metformin Associated Lactic Acidosis (MALA)- an In Silico Exploration

, 2018; 16(3): 199 - 209

Siddiqur Rahman, Tamim Ahsan, Riajul Hossain, Tasnim Ahmed and Abu Ashfaqur Sajib*




Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations

, 2018; 16(3): 192 - 198

Dmitry L. Maslov*, Elena E. Balashova, Oxana P. Trifonova and Petr G. Lokhov






Individualized Cancer Therapy, Future Approaches

, 2018; 16(2): 156 - 163

Da-Yong Lu*, Ting-Ren Lu, Bin Xu, Jin-Yu Che, Ying Shen and Nagendra Sastry Yarla














Most Cited Articles

Cardiovascular Pharmacogenomics

, 2017; 15(1): 67-80.

Valentina Manzo*, Sara Tarallo, Teresa Iannaccone, Maria Costantino, Walter Filippelli and Amelia Filippelli


DOI: 10.2174/1875692115666170503124456



Impact of New Technologies on Pharmacogenomics

, 2016; 14(2): 74-85.

Maria Isidoro-Garcia*, Almudena Sanchez-Martin and Belen Garcia-Berrocal


DOI: 10.2174/1875692115666170214152152



Most Accessed Articles







Individualized Cancer Therapy, Future Approaches

, 2018; 16(2): 156-163.

Da-Yong Lu*, Ting-Ren Lu, Bin Xu, Jin-Yu Che, Ying Shen and Nagendra Sastry Yarla


DOI: 10.2174/1875692116666180821095434